U.S. Logistics Stock News

Equity Residential stock has delivered a 16.8% total return over the past three years, while a fresh Discounted Cash Flow (DCF) intrinsic value estimate suggests the shares may still trade below what the underlying cash flows imply, and recent merger headlines add a new layer of uncertainty to that picture. The 16.8% three year return points to steady shareholder gains, rather than a sharp rerating that would clearly exhaust valuation upside. Expected revenue and operating income growth,...

HA Sustainable Infrastructure Capital (NYSE:HASI) issued $1 billion in green senior unsecured notes to fund eligible green projects. The company was added to the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index. The new green financing is intended for both new and existing sustainable infrastructure projects. HA Sustainable Infrastructure Capital, trading at $38.63, is positioned at the intersection of listed equities and green infrastructure financing. The stock is...

Keel Infrastructure (NasdaqGM:KEEL) has reported delays and cost overruns on a flagship project, contributing to substantial quarterly losses. The company is facing renewed regulatory scrutiny at the same time as it is being added to multiple Russell indexes. These developments raise questions about long term profitability and operational execution for Keel Infrastructure. Keel Infrastructure operates in a capital intensive sector where large projects, regulatory oversight, and index...

BlackSky Technology (BKSY) is back in focus after a contract modification from the National Reconnaissance Office lifted the value of its AROS satellite program above $150 million, along with a new multi-year imaging services agreement. See our latest analysis for BlackSky Technology. Recent news around the AROS contract and new imaging work comes after a mixed year for BlackSky Technology. The share price is up 38.04% year to date, but the 30 day share price return declined 32.19%. The 3...

Anyone interested in Viemed Healthcare, Inc. ( NASDAQ:VMD ) should probably be aware that the Independent Director...

We wouldn't blame Vaxcyte, Inc. ( NASDAQ:PCVX ) shareholders if they were a little worried about the fact that Grant...

First Financial Bancorp (FFBC) stock has been in focus after the bank reported quarterly revenue of $265.8 million, which was 26.1% higher than a year earlier and 3.1% above analyst expectations. See our latest analysis for First Financial Bancorp. First Financial Bancorp’s recent earnings beat has coincided with strong momentum, with a 15.5% 1 month share price return and a 38.2% year to date share price return. The 3 year total shareholder return of 90.9% points to a solid longer term...

Recent analyst coverage has put Federal Agricultural Mortgage (AGM) back in focus, highlighting its multi segment business model and consistent operational execution as investors reassess mortgage related stocks in a period of high rates. See our latest analysis for Federal Agricultural Mortgage. Those themes are showing up in the share price, with Federal Agricultural Mortgage’s 30 day share price return of 13.88% and 90 day share price return of 35.14% at a last close of $203.11, while the...

The Humana Foundation, the philanthropic arm of Humana Inc., recently committed over US$12.20 million in 2026 grants to support emotional well-being programs and research targeting loneliness, depression, and social isolation among seniors and veterans across multiple states. While these grants highlight Humana’s broader role in senior health, recent analyst coverage instead focuses on its Medicare Advantage revenue outlook and premium valuation as key drivers of investor interest. Next,...

Chemours (CC) stock is in focus after the company agreed to a regulatory settlement over PFAS discharges, committing to a US$22.5 million civil penalty and US$90 million of long term mitigation projects. See our latest analysis for Chemours. The PFAS settlement landed after a strong run for Chemours, with the share price up 64.41% year to date at US$20.14. However, recent 30 day and 7 day share price returns of 9.77% and 4.87% respectively indicate that momentum has cooled and reflect longer...

Molina Healthcare (MOH) is in focus after new 2025 risk adjustment figures from the Centers for Medicare & Medicaid Services pointed to higher than expected payments for the company, alongside fresh index reclassifications and value-focused research coverage. See our latest analysis for Molina Healthcare. The recent risk adjustment update and index reshuffling come at a time when Molina Healthcare’s share price momentum has been strong, with a 30 day share price return of 26.9% and a 90 day...

In late June 2026, Absci Corporation reported positive interim Phase 1 data from its HEADLINE trial of ABS-201 for androgenetic alopecia, showing favorable safety, an estimated half-life of at least 65 days, and progression into multiple ascending dose cohorts, while also completing a US$100.00 million follow-on equity offering of 13,495,277 common shares at US$7.41 each. The combination of encouraging early data for a long-acting, antibody-based hair loss therapy and fresh equity capital...

W. R. Berkley (NYSE:WRB) has announced the resignation of Executive Vice President Lucille Sgaglione. The company has appointed John Enright as president of Berkley Specialty London. These leadership moves affect a key business segment that draws attention from investors tracking executive decision making. W. R. Berkley enters these leadership changes with its stock at $70.66 and a long term return of 134.5% over the past 5 years. Over the past 3 years, the stock is up 92.2%, while the 1...

Zions Bancorporation National Association (ZION) has been added to the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index, a shift that can influence institutional attention and index-tracking fund flows. See our latest analysis for Zions Bancorporation National Association. Zions Bancorporation National Association has seen momentum build recently, with a 1 month share price return of 15.75% and a 1 year total shareholder return of 33.25%, alongside a very large 3 year...

With the Federal Reserve expected to keep the effective funds rate around 3.63% to 3.64% through 2026 and core PCE inflation sitting at 3.3%, income focused investors are paying closer attention to how reliable dividend stocks handle a long stretch of steady rates. Rather than chasing whatever is moving, it can help to focus on large, established companies that already have a history of consistent payouts. This article looks at three dividend stocks from our screener that appear closely tied...

We wouldn't blame Oscar Health, Inc. ( NYSE:OSCR ) shareholders if they were a little worried about the fact that Mark...

On June 27, 2026, Acadia Healthcare Company was removed from the Russell 1000, Midcap and related value/dynamic benchmarks, while being added to the Russell 2000 Index and its value and dynamic counterparts as part of the Russell index reconstitution. This shift effectively recategorizes Acadia Healthcare into the smaller‑capitalization value universe, which can alter its investor base, trading liquidity and how portfolio managers frame its role within behavioral health exposure. Next, we’ll...

MasTec, Inc. recently added veteran utility executive Manny Miranda to its Board as a Class II Director, while the company was also removed from several Russell value and growth benchmarks in late June 2026. His four decades of hands-on experience in electric and natural gas utility operations could deepen MasTec’s insight into grid modernization and energy infrastructure challenges. With Miranda’s utility expertise now on the board, we’ll examine how these developments may influence...

Advanced Energy Industries (AEIS) has been catching investor attention after a sharp move in the stock, supported by strong sector momentum, upbeat semiconductor spending forecasts, recent Russell index inclusions, and activity around new AI data center products. See our latest analysis for Advanced Energy Industries. The share price of Advanced Energy Industries has eased 4.4% over the last day and is roughly flat over the past week. However, a 20.9% 1 month share price return and 60.5% year...

Index inclusions put Genius Sports in focus Genius Sports (GENI) is drawing fresh investor attention after being added to several Russell value indices, including the Russell 2000 Value and 2500 Value benchmarks, a shift that can influence institutional demand. See our latest analysis for Genius Sports. The index inclusions arrive after a sharp 39.47% 90 day share price return and a 12.37% 7 day share price return, set against a year to date share price decline of 41% and a 1 year total...

Sensient Technologies recently entered into a new unsecured delayed-draw term loan credit facility of up to US$400,000,000, maturing in five years, to refinance existing debt and support working capital and other general corporate purposes. The agreement’s flexible draw structure, leverage and interest coverage covenants, and option to prepay without penalty could meaningfully influence Sensient’s balance sheet management and funding costs. We’ll now examine how this US$400,000,000...

ACV Auctions (ACVA) was added to several Russell value and small cap benchmarks, including the Russell 2000 Value and Russell 3000 Value indices. This shift can influence index fund activity and overall investor attention. See our latest analysis for ACV Auctions. ACV Auctions' inclusion in several Russell value indices comes after a sharp 67.2% 3 month share price return to US$7.29, even though the year to date share price return is down 12.06% and the 1 year total shareholder return has...

In late June 2026, JPMorgan upgraded its rating on Qualys after reassessing the company’s position in the expanding vulnerability management segment and broader cybersecurity services market. This reassessment highlights how Qualys’ core role in helping enterprises proactively identify and prioritize security risks is becoming more central as organizations modernize their defenses. We’ll now explore how this renewed confidence in Qualys’ vulnerability management strength may influence its...

PROCEPT BioRobotics (PRCT) drew fresh attention after Evercore ISI initiated coverage, alongside two new Aquablation milestones: full enrollment in the WATER IV RP trial and FDA IDE approval for a second prostate cancer study. See our latest analysis for PROCEPT BioRobotics. At a share price of US$23.47, PROCEPT BioRobotics has seen a 7 day share price return of 12.57% following the Evercore ISI coverage and clinical milestones, but this sits against a 1 year total shareholder return that...